Differential susceptibility of muscles to myotonia and force impairment in a mouse model of myotonic dystrophy
- PMID: 21404300
- DOI: 10.1002/mus.21988
Differential susceptibility of muscles to myotonia and force impairment in a mouse model of myotonic dystrophy
Abstract
Introduction: Myotonic dystrophy, or dystrophia myotonica (DM), is characterized by prominent muscle wasting and weakness as well as delayed muscle relaxation resulting from persistent electrical discharges.
Methods: We hypothesized heterogeneity among muscles in degree of weakness and myotonia in an expanded [(CUG)(250)] repeats transgenic (HSA(LR)) mouse DM model. Muscle contraction was compared among diaphragm, extensor digitorum longus (EDL), and soleus muscles.
Results: Myotonia was found only in EDL, as manifested by longer late-relaxation time and elevated myotonic index. EDL, but not the other two muscles, had impaired force over a wide range of stimulation frequencies. During fatigue-inducing stimulation, DM EDL muscle force per cross-sectional area was significantly impaired during 25-Hz stimulation, whereas there were no differences in fatigue response for DM diaphragm or soleus.
Conclusion: In an expanded repeats model of DM the EDL is more susceptible to myotonia and force impairment than muscles with lower proportions of fast-twitch fibers.
Copyright © 2010 Wiley Periodicals, Inc.
Similar articles
-
Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.Muscle Nerve. 2007 Apr;35(4):479-85. doi: 10.1002/mus.20722. Muscle Nerve. 2007. PMID: 17230537 Clinical Trial.
-
Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway.Neuromuscul Disord. 2010 May;20(5):319-25. doi: 10.1016/j.nmd.2010.03.006. Epub 2010 Mar 25. Neuromuscul Disord. 2010. PMID: 20346670
-
Myotonic dystrophy type 2 with focal asymmetric muscle weakness and no electrical myotonia.Muscle Nerve. 2009 Mar;39(3):383-5. doi: 10.1002/mus.21150. Muscle Nerve. 2009. PMID: 19208413
-
The myotonic dystrophies.Semin Neurol. 1999;19(1):25-33. doi: 10.1055/s-2008-1040823. Semin Neurol. 1999. PMID: 10711986 Review.
-
RNA pathogenesis of the myotonic dystrophies.Neuromuscul Disord. 2005 Jan;15(1):5-16. doi: 10.1016/j.nmd.2004.09.012. Epub 2004 Nov 26. Neuromuscul Disord. 2005. PMID: 15639115 Review.
Cited by
-
Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy.Mol Ther Nucleic Acids. 2020 Nov 26;23:393-405. doi: 10.1016/j.omtn.2020.11.014. eCollection 2021 Mar 5. Mol Ther Nucleic Acids. 2020. PMID: 33473325 Free PMC article.
-
Molecular mechanisms of muscle atrophy in myotonic dystrophies.Int J Biochem Cell Biol. 2013 Oct;45(10):2280-7. doi: 10.1016/j.biocel.2013.06.010. Epub 2013 Jun 21. Int J Biochem Cell Biol. 2013. PMID: 23796888 Free PMC article. Review.
-
Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I.J Clin Invest. 2017 Feb 1;127(2):549-563. doi: 10.1172/JCI89616. Epub 2017 Jan 9. J Clin Invest. 2017. PMID: 28067669 Free PMC article.
-
CaMKIIβ deregulation contributes to neuromuscular junction destabilization in Myotonic Dystrophy type I.Skelet Muscle. 2024 May 21;14(1):11. doi: 10.1186/s13395-024-00345-3. Skelet Muscle. 2024. PMID: 38769542 Free PMC article.
-
Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.PLoS Genet. 2012;8(11):e1003043. doi: 10.1371/journal.pgen.1003043. Epub 2012 Nov 29. PLoS Genet. 2012. PMID: 23209425 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
